Hepatitis Test Solution and Diagnosis Market – Global Industry Analysis & Forecast (2023-2029)


Hepatitis Test Solution and Diagnosis Market is expected to account for USD 5.94 billion by 2029 and expanding at a CAGR of nearly 5.2 % in the forecast period of 2023 to 2029.

Hepatitis Test Solution and Diagnosis Market Dynamics

Global Hepatitis Health Sector on Viral Hepatitis is stated that 30% of the persons living with HBV and HCV by 2022 and it is expected to reach 90% by 2030. These improve the clinical outcomes and save lives, as well as reducing hepatitis transmission and new infections. The development of highly effective, well-tolerated oral direct-acting antiviral (DAA) treatment regimens with high rates of cure after 8–12 weeks of treatment has to make revolutions in hepatitis test solutions and diagnostics.Hepatitis Test Solution and Diagnosis MarketTo know about the Research Methodology :- Request Free Sample Report

Available resources for effective long-term antiviral treatment with tenofovir or entecavir are the major driver for the global market. The high increase in global burden regarding the diagnostic treatments for the hepatitis disease and the advances and opportunities for treatment led to give the growth opportunities for the global market. Cost-effective diagnostic tests and evidence-based evolutions in the performance of the diagnostic tests as well as testing strategies make the treatments available for the patients and helps to increase the awareness of the tests among them.

Evidence-based ongoing studies on the hepatitis virus from countries from Asia, North America, and Western Europe and the availability of a large amount of data for further studies create the roadmap for further hepatitis testing. The high prices of these new medicines remain a major barrier to access growth of the global market in many countries.

Global Hepatitis Test Solution and Diagnosis Market Segment Analysis:

The report groups the Global Hepatitis Test Solution and Diagnosis Market in different segments By Disease Type, Technology, End-User and Region to forecast the revenues and analyze the market share of each segment over the forecast period.

Based on Disease Type, the Global Hepatitis Test Solution and Diagnosis Market is segmented into Hepatitis B, HCV, HAV, HDV. The Hepatitis B segment was dominant in 2022 and is expected to command a market share of xx% by 2029. Hepatitis B virus (HBV) infection is a major cause of acute and chronic liver disease globally and it causes an estimated 1.4 million deaths annually. Till today, 248 million people are suffering from chronic HBV infection, and that 110 million persons are HBV-antibody positive.

Chronic HBV is a disproportionately major burden for the population mainly from low- and middle-income countries (LMICs), particularly in Asia and Africa. Additionally, even in low-prevalence areas, certain populations have high levels of HCV infection, these factors driving the global hepatitis test and diagnosis market in the globe.

PCR Segment was dominant in 2022 and is expected to command a market share of xx% by 2029.

At present, polymerase chain reaction (PCR) is the dominant way that global healthcare systems are testing citizens for hepatitis. At the moment the majority of the current hepatitis tests that all the reports are coming from are using PCR. It is the largest conducting test across the global laboratories to detect the hepatitis antigen present in the human body.

The convenient home-based hepatitis PCR test has a high demand for early detection of the same. Because hepatitis exhibits a range of clinical manifestations, from mild flu-like symptoms to life-threatening conditions, it is important to have efficient RT-PCR testing during the early stages of infection to identify hepatitis patients from those with other illnesses. This avoids unnecessary deaths of individuals and the spread of infection by positive individuals.

Global Hepatitis Test Solution and Diagnosis Market Regional Analysis:

Asia Pacific is expected to command the largest market share of XX% by 2029.

Developed healthcare facilities in the Asia Pacific countries like the Malaysia, India, China and the large populations suffering from hepatitis are driven by the global market. Evolutions in the laboratory testing facilities and improvements in the hepatitis diagnostic testing facilities help to improve the testing facilities and save the lives of the individuals. Currently, vast access to diagnostics tests, antiviral therapies, and appropriate laboratory infrastructure are impelling the global market in the Asia Pacific region.

In the Asia Pacific, there is a huge scope for opportunities to improve the identification and treatment of persons with chronic hepatitis B and C. Approximately 60% of the world’s population live in areas where HBV infection is highly endemic, particularly in Asia and Africa. Peoples from the Asia Pacific Countries most peoples are infected with HBV and/or HCV remain unaware of their infection. Many countries of Asia Pacific are equipped with low-income countries where many of the peoples are infected with Hepatitis and the infection spreads easily which in these regions are likely drives the global market in this region.

The objective of the report is to present a comprehensive analysis of the Global Hepatitis Test Solution and Diagnosis Market to the stakeholders in the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the Global Hepatitis Test Solution and Diagnosis Market dynamics, structure by analyzing the market segments and projects the Global Hepatitis Test Solution and Diagnosis Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Hepatitis Test Solution and Diagnosis Market make the report investor’s guide.

Global Hepatitis Test Solution and Diagnosis Market Report Scope: Inquire before buying






Global Hepatitis Test Solution and Diagnosis Market




Report Coverage
Details




Base Year:
2022
Forecast Period:
2023-2029




Historical Data:
2018 to 2022
Market Size in 2022:
US $ 4.16 Bn.




Forecast Period 2023 to 2029 CAGR:
5.2%
Market Size in 2029:
US $ 5.94 Bn.




 Segments Covered:
by Disease Type
Hepatitis B
HCV
HAV
HDV




by Technology
ELISA
RDT
PCR
Transcription Mediated Amplification




by End-User
Hospitals
Diagnostic Laboratories
Blood Banks






Hepatitis Test Solution and Diagnosis Market, by Region

Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players

1. F. Hoffmann-La Roche Ltd
2. Abbott Laboratories
3. Bio-Rad
4. Siemens
5. DiaSorin
6. QIAGEN
7. Danaher
8. bioMérieux
9. Grifols
10. Ortho Clinical Diagnostics
11. FUJIREBIO Inc.
12. Avantor Inc.
13. Quest Diagnostics Incorporated
14. MedMira Inc.
15. Laboratory Corporation of America Holdings
16. Cigna
17. OraSure Technologies Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Hepatitis Test Solution and Diagnosis Market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Hepatitis Test Solution and Diagnosis Market?
Ans: The Global market is growing at a CAGR of 5.2% during forecasting period 2023-2029.

3. What is scope of the Global Hepatitis Test Solution and Diagnosis market report?
Ans: Global market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Hepatitis Test Solution and Diagnosis market?
Ans: The important key players in the Global market are – F. Hoffmann-La Roche Ltd, Abbott Laboratories, Bio-Rad, Siemens, DiaSorin, QIAGEN, Danaher, bioMérieux, Grifols, Ortho Clinical Diagnostics, FUJIREBIO Inc., Avantor Inc., Quest Diagnostics Incorporated, MedMira Inc., Laboratory Corporation of America Holdings, Cigna, and OraSure Technologies Inc.

5. What is the study period of this market?
Ans: The Global market is studied from 2022 to 2029. 




1.Preface
1.1. Market Definition and Key Research Objectives
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Report Assumptions
2.2. Abbreviations
2.3. Research Methodology
2.3.1. Secondary Research
2.3.1.1. Secondary data
2.3.1.2. Secondary Sources
2.3.2. Primary Research
2.3.2.1. Data from Primary Sources
2.3.2.2. Breakdown of Primary Sources
3. Executive Summary: Global Hepatitis Test Solution and Diagnosis Market Size, by Market Value (US$ Bn)
3.1. Global Market Segmentation
3.2. Global Market Segmentation Share Analysis, 2022
3.2.1. Global
3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
3.3. Geographical Snapshot of the Hepatitis Test Solution and Diagnosis Market
3.4. Geographical Snapshot of the Hepatitis Test Solution and Diagnosis Market, By Manufacturer share
4. Global Hepatitis Test Solution and Diagnosis Market Overview, 2022-2029
4.1. Market Dynamics
4.1.1. Drivers
4.1.1.1. Global
4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.2. Restraints
4.1.2.1. Global
4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.3. Opportunities
4.1.3.1. Global
4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.4. Challenges
4.1.4.1. Global
4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa)
4.1.5. Industry Trends and Emerging Technologies
4.1.6. Porters Five Forces Analysis
4.1.6.1. Threat of New Entrants
4.1.6.2. Bargaining Power of Buyers/Consumers
4.1.6.3. Bargaining Power of Suppliers
4.1.6.4. Threat of Substitute Products
4.1.6.5. Intensity of Competitive Rivalry
4.1.7. Value Chain Analysis
4.1.8. Technological Roadmap
4.1.9. Regulatory landscape
4.1.10. Impact of the Covid-19 Pandemic on the Global Hepatitis Test Solution and Diagnosis Market
5. Supply Side and Demand Side Indicators
6. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecast, 2022-2029
6.1. Global Hepatitis Test Solution and Diagnosis Market Size & Y-o-Y Growth Analysis.
7. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
7.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
7.1.1. Hepatitis B
7.1.2. HCV
7.1.3. HAV
7.1.4. HDV
7.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
7.2.1. ELISA
7.2.2. RDT
7.2.3. PCR
7.2.4. Transcription Mediated Amplification
7.3. Market Size (Value) Estimates & Forecast By End-User, 2022-2029
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Blood Banks
7.3.4. Nursing Homes
8. Global Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Region
8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029
8.1.1. North America
8.1.2. Europe
8.1.3. Asia-Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9. North America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
9.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
9.1.1. Hepatitis B
9.1.2. HCV
9.1.3. HAV
9.1.4. HDV
9.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
9.2.1. ELISA
9.2.2. RDT
9.2.3. PCR
9.2.4. Transcription Mediated Amplification
9.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
9.3.1. Hospitals
9.3.2. Diagnostic Laboratories
9.3.3. Blood Banks
9.3.4. Nursing Homes
10. North America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Country
10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
10.1.1. US
10.1.2. Canada
10.1.3. Mexico
11. U.S. Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
11.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
11.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
11.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
12. Canada Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
12.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
12.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
12.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
13. Mexico Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
13.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
13.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
13.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
14. Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
14.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
14.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
14.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
15. Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, By Country
15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
15.1.1. U.K
15.1.2. France
15.1.3. Germany
15.1.4. Italy
15.1.5. Spain
15.1.6. Sweden
15.1.7. CIS Countries
15.1.8. Rest of Europe
16. U.K. Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
16.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
16.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
16.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
17. France Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
17.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
17.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
17.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
18. Germany Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
18.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
18.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
18.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
19. Italy Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
19.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
19.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
19.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
20. Spain Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
20.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
20.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
20.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
21. Sweden Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
21.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
21.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
21.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
22. CIS Countries Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
22.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
22.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
22.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
23. Rest of Europe Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
23.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
23.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
23.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
24. Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
24.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
24.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
24.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
25. Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country
25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029
25.1.1. China
25.1.2. India
25.1.3. Japan
25.1.4. South Korea
25.1.5. Australia
25.1.6. ASEAN
25.1.7. Rest of Asia Pacific
26. China Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
26.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
26.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
26.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
27. India Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
27.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
27.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
27.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
28. Japan Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
28.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
28.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
28.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
29. South Korea Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
29.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
29.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
29.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
30. Australia Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
30.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
30.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
30.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
31. ASEAN Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
31.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
31.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
31.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
32. Rest of Asia Pacific Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
32.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
32.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
32.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
33. Middle East Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
33.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
33.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
33.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
34. Middle East Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country
34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
34.1.1. South Africa
34.1.2. GCC Countries
34.1.3. Egypt
34.1.4. Nigeria
34.1.5. Rest of ME&A
35. South Africa Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
35.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
35.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
35.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
36. GCC Countries Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
36.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
36.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
36.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
37. Egypt Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
37.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
37.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
37.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
38. Nigeria Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
38.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
38.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
38.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
39. Rest of ME&A Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
39.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
39.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
39.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
40. South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
40.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
40.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
40.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
41. South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, by Country
41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029
41.1.1. Brazil
41.1.2. Argentina
41.1.3. Rest of South America
42. Brazil Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
42.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
42.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
42.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
43. Argentina Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
43.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
43.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
43.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
44. Rest of South America Hepatitis Test Solution and Diagnosis Market Analysis and Forecasts, 2022-2029
44.1. Market Size (Value) Estimates & Forecast By Disease Type, 2022-2029
44.2. Market Size (Value) Estimates & Forecast By Technology, 2022-2029
44.3. Market Size (Value) Estimates & Forecast By End-Users, 2022-2029
45. Competitive Landscape
45.1. Geographic Footprint of Major Players in the Global Hepatitis Test Solution and Diagnosis Market
45.2. Competition Matrix
45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment
45.2.2. New Product Launches and Product Enhancements
45.2.3. Market Consolidation
45.2.3.1. M&A by Regions, Investment and Verticals
45.2.3.2. M&A, Forward Integration and Backward
Integration
45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
45.3. Company Profile : Key Players
45.3.1. F. Hoffmann-La Roche Ltd
45.3.1.1. Company Overview
45.3.1.2. Financial Overview
45.3.1.3. Geographic Footprint
45.3.1.4. Product Portfolio
45.3.1.5. Business Strategy
45.3.1.6. Recent Developments
45.3.2. Abbott Laboratories
45.3.3. Bio-Rad
45.3.4. Siemens
45.3.5. DiaSorin
45.3.6. QIAGEN
45.3.7. Danaher
45.3.8. bioMérieux
45.3.9. Grifols
45.3.10. Ortho Clinical Diagnostics
45.3.11. FUJIREBIO Inc.
45.3.12. Avantor Inc.
45.3.13. Quest Diagnostics Incorporated
45.3.14. MedMira Inc.
45.3.15. Laboratory Corporation of America Holdings
45.3.16. Cigna
45.3.17. OraSure Technologies Inc.
46. Primary Key Insights
  • INQUIRE BEFORE BUYING